Fenretinide

A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Also Known As:

4-Hydroxyphenylretinamide; Fenretinide, 13-cis-Isomer; Fenretinimide; MCN-R-1967; N-(4-Hydroxyphenyl)-trans-Retinamide; N-(4-Hydroxyphenyl)retinamide; 13-cis-Isomer Fenretinide; 4 Hydroxyphenylretinamide; Fenretinide, 13 cis Isomer; MCN R 1967; MCNR1967; 4-HPR; Retinamide, N-(4-hydroxyphenyl)-

Pharmalogical Action Categories:

Anticarcinogenic Agents
Antineoplastic Agents

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Terpenes: 1531
    - Carotenoids: 4191
      - Retinoids: 5971
        Fenretinide: 664
  - Cyclic Hydrocarbons: 96
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclohexanes: 3
        Cyclohexenes: 5
        Carotenoids: 4191
        Retinoids: 5971
        Fenretinide: 664
  - Acyclic Hydrocarbons
    - Alkenes: 270
      - Polyenes: 167
        Carotenoids: 4191
        Retinoids: 5971
        Fenretinide: 664
Biological Factors: 2560
- Biological Pigments: 1
  - Carotenoids: 4191
    - Retinoids: 5971
      - Fenretinide: 664

Sarah Altman Selected Research

Sarah Altman Research Topics

Disease

Drug/Important Bio-Agent (IBA)